Status:
COMPLETED
Pulmonary Embolism: Mechanism and Therapeutic Innovation
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
Detailed Description
The study recruited consecutive outpatients or hospitalized patients diagnosed with pulmonary embolism (PE cohort) and chronic thromboembolic pulmonary hypertension (CTEPH cohort). The follow-up of al...
Eligibility Criteria
Inclusion
- All hospitalized patients or outpatients diagnosed with PE or CTEPH;
- Age ≥18.
Exclusion
- Refused informed consents.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 13 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05360992
Start Date
January 1 2017
End Date
October 13 2021
Last Update
May 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.